In a healthcare environment where safety, consistency, and staff protection are non‑negotiable, EQUASHIELD® continues to ...
PORT WASHINGTON, N.Y., May 22, 2025 /PRNewswire/ -- EQUASHIELD ®, a global leader in Closed System Transfer Devices (CSTDs) and automated compounding solutions, proudly announces that it has been ...
PORT WASHINGTON, N.Y., Sept. 8, 2023 /PRNewswire/ -- EQUASHIELD, a pioneer in closed system transfer devices (CSTDs) and automated pharmacy compounding solutions, is thrilled to announce its ...
Satellite Symposium at ISOPP 2018Focusing on Robotics in Cytotoxics to Feature Leading Experts an Augmented Reality Tour of Equashield Pro Hazardous Drug Compounding Robot Equashield (equashield.com), ...
Equashield, a leading provider of Closed System Transfer Devices (CSTD) for safe and simple handling of hazardous drugs, announced today that it is expanding its range of solutions and products ...
The Barbara Ann Karmanos Cancer Institute in Detroit treats thousands of oncology patients each year for serious and often life-threatening medical conditions. But not too many people consider the ...
The deal puts Equashield at a valuation of $300 million Equashield was founded in 2009 Since inception in 1989, Nordic Capital has invested more than 20 billion euros in equity capital in over 125 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results